Equasens Société anonyme (EPA: EQS)
France
· Delayed Price · Currency is EUR
41.60
+0.90 (2.21%)
Nov 22, 2024, 5:35 PM CET
Equasens Société anonyme Revenue
Equasens Société anonyme had revenue of 107.17M EUR in the half year ending December 31, 2023, with 8.07% growth. This brings the company's revenue in the last twelve months to 215.16M, down -1.58% year-over-year. In the year 2023, Equasens Société anonyme had annual revenue of 219.79M with 2.67% growth.
Revenue (ttm)
215.16M
Revenue Growth
-1.58%
P/S Ratio
2.91
Revenue / Employee
169.28K
Employees
1,271
Market Cap
625.30M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 219.79M | 5.71M | 2.67% |
Dec 31, 2022 | 214.08M | 21.01M | 10.88% |
Dec 31, 2021 | 193.07M | 21.32M | 12.41% |
Dec 31, 2020 | 171.75M | 13.19M | 8.31% |
Dec 31, 2019 | 158.57M | 10.09M | 6.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 48.45B |
EssilorLuxottica Société anonyme | 25.83B |
Sartorius Stedim Biotech S.A. | 2.74B |
bioMérieux S.A. | 3.81B |
Ipsen S.A. | 3.44B |
Eurofins Scientific SE | 6.72B |
Virbac SA | 1.34B |
Ramsay Générale de Santé SA | 5.01B |